Securities code: 600518 securities abbreviation: * ST Kangmei Announcement No.: 2022-011 Kangmei Pharmaceutical Co.Ltd(600518)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips: whether there is a veto proposal at this meeting: none. The convening and attendance of the meeting
（1） Time of the general meeting of shareholders: January 25, 2022
（2） Venue of the general meeting of shareholders: conference room (III) of phase II complex building of Kangmei Pharmaceutical Co.Ltd(600518) traditional Chinese medicine production base, Puning science and Technology Industrial Park, Guangdong Province ordinary shareholders attending the meeting and preferred shareholders who have restored their voting rights and their shares:
1. Number of shareholders and proxies attending the meeting 325
2. Total number of voting shares held by shareholders attending the meeting (shares) 5057142654
3. The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares
Proportion of total copies (%) 36.4771
（4） Whether the voting method complies with the provisions of the company law and the articles of association, and the chairmanship of the general meeting. This meeting adopts a combination of on-site voting and online voting, which is in line with the provisions of the company law and the articles of association. The meeting is presided over by Mr. Ma Xinggu, chairman of the company.
（5） Attendance of directors, supervisors and Secretary of the board of directors of the company
1. There were 9 directors of the company and 7 attended the meeting. Mr. Zhou Wei, vice chairman and Mr. Guo Chonghui, independent director, did not attend the meeting due to the epidemic;
2. There were 3 supervisors of the company and 2 attended the meeting. Mr. Ke Jing, chairman of the board of supervisors, did not attend the meeting due to the epidemic situation; 3. The Secretary of the board of directors is present; Some senior executives of the company attended as nonvoting delegates. 2、 Proposal deliberation (I) cumulative voting 1. Proposal on the election of non independent directors of the ninth board of directors of the company
The number of votes in attendance
Proposal serial number proposal name number of votes obtained the proportion of effective voting right of the meeting (%)
1.01 Lai Zhijian 5021404191 99.2933 yes
1.02 Mickey 5019872661 99.2630 yes
1.03 Liu Guowei 5020636122 99.2781 yes
1.04 Liang Jun 5019684659 99.2593 yes
1.05 Yang Weirong 5017864608 99.2233 yes
1.06 Fang miaoshuang 5017746886 99.2210 yes
2. Proposal on the election of independent directors of the ninth board of directors of the company
The number of votes in attendance
Proposal serial number proposal name number of votes obtained the proportion of effective voting right of the meeting (%)
2.01 Luo Tao 5019888878 99.2633 yes
2.02 Lai Xiaoping 5018510942 99.2361 yes
2.03 Zeng Qing 5019690283 99.2594 yes
3. Proposal on the election of non employee representative supervisors of the ninth board of supervisors of the company
The number of votes in attendance
Proposal serial number proposal name number of votes obtained the proportion of effective voting right of the meeting (%)
3.01 Gao Yanzhu 5019866696 99.2629 yes
3.02 Wang Tong 5018096951 99.2279 yes
（2） Voting of less than 5% of shareholders involved in major issues
Name of the proposal: agree against abstention
Proportion of No. votes (%) proportion of votes (%) proportion of votes (%)
1.01 Lai Zhijian 24805762 40.9713 —-
1.02 Mickey 23274232 38.4417 —-
1.03 Liu Guowei 24037693 39.7027 —-
1.04 Liang Jun 23086230 38.1311 —-
1.05 Yang Weirong 21266179 35.1250 —-
1.06 Fang miaoshuang 21148457 34.9305 —-
2.01 Luo Tao 23290449 38.4684 —-
2.02 Lai Xiaoping 21912513 36.1925 —-
2.03 Zeng Qing 23091854 38.1404 —-
3.01 Gao Yanzhu 23268267 38.4318 —-
3.02 Wang Tong 21498522 35.5087 —-
（3） Explanation on the voting of proposals
1. The meeting adopted a combination of on-site voting and online voting, and adopted all proposals.
2. Proposals 1, 2 and 3 are cumulative voting proposals, and each sub proposal is listed by cumulative voting
The resolutions have been deliberated and adopted at this shareholders’ meeting.
3、 Lawyer witness
1. Law firm witnessed at this shareholders’ meeting: Guangdong Xinda law firm
Lawyers: Ma Dongmei, he Lingyi
2. Lawyer’s Witness conclusion:
Cinda law firm believes that the convening and convening procedures of the general meeting of shareholders of the company comply with the company law and the shareholders’ agreement
Rules of the general meeting, detailed rules for the implementation of online voting at the general meeting of shareholders and other laws, regulations, normative documents and the company
Provisions of the articles of Association; The qualifications of attendees and conveners are legal and valid; Voting at the general meeting of shareholders
The procedures and voting results are legal and valid. 4、 List of documents for reference 1. Kangmei Pharmaceutical Co.Ltd(600518) resolution of the first extraordinary general meeting of shareholders in 2022; 2. Legal opinion of Guangdong Xinda law firm on Kangmei Pharmaceutical Co.Ltd(600518) the first extraordinary general meeting of shareholders in 2022.
Kangmei Pharmaceutical Co.Ltd(600518) January 26, 2022
